Please join us at the 34th Annual Meeting of the Society for Thermal Medicine in Cancun, Mexico. I know some of you are still experiencing winter, so enticing you with ocean water temperatures of 81˚F would be unfair.  But supporting and participating in the advancement of the hyperthermia industry is a good thing.

This years meeting will be held April 29th thru May 2nd at the CasaMagna Marriott Cancún Resort.  The 2017 Program Chair is Robert Ivkov from the Department of Radiation Oncology at Johns Hopkins University School of Medicine.  You can register for the conference at the STM website, thermaltherapy.org. The full conference program is available here.

The conference is shaping up to feature an outstanding line-up of the world’s thought leaders and prominent researchers presenting cutting-edge developments in biology, physics, engineering, and clinical applications of thermal medicine. Our CTO, long time STM member and industry expert, Paul Turner will be in attendance.  Jason Ellsworth, our VP of Engineering, will be a featured speaker at the event. And as the company CEO, I will be available to field any questions about the direction Pyrexar is taking to expand the global market.

In addition to being an event gold sponsor, Pyrexar has invited several hyperthermia luminaries from the ESHO (European Society of Hyperthermic Oncology). Dr. Niloy Datta, Dr. Rolf Issels and Dr. Jacoba Van der Zee will be there to speak at the event and share their experiences.

 

stm cancun

With the increased attention worldwide on immunotherapy, the future of radiation therapy as a monotherapy is at risk of losing ground as the standard of care. In order to fight radio-resistant tumor types, oncologists are reaching for treatment solutions that can close the performance gap of existing therapies to increase tumor control. Monotherapy treatments, like radiation therapy, are being pushed aside by dual-therapy treatment programs. So what can be done to increase radio sensitivity, reduce toxicity and improve outcomes?

RF hyperthermia is one such dual-therapy technology that is leading the charge. Hyperthermia is an ideal adjunct therapy for radiation resistant tumors. Focused energy applied to the tumor site (targeting tumor heating of 41 C) is a highly effective radio-sensitizer. In addition, provides this heightened benefit with little to no-toxic effect to the patient.

  • Known benefits of hyperthermia include:
  • Increased oxygenation of the tumor site.
  • Inhibits DNA repair.
  • Assist in cell death during cellular s-phase.
  • Increases in effective Gy dose by as much as 150 percent.

Phase III clinical studies have shown dramatic improvement of tumor control and long-term patient survival by adding RF hyperthermia. Targeted heating within four hours before or after radiation therapy can increase the radiosensitivity of the cancer tumor. The benefit of increased oxygenation of the tumor site can remain for up to 24 hours.

The Pyrexar family of highly reliable, deep regional and superficial/interstitial hyperthermia systems are based on 30 years of product development and tens of thousands of patient treatments. Pyrexar cancer treatment devices use radio frequency to deliver focused energy to the tumor site. This technology allows for superior heating of most soft tissue tumors, provides temperature mapping and treatment zone control, with emphasis on patient comfort.

At this year’s RSNA trade show in Chicago, Pyrexar will be introducing the next step in image guided thermal therapy, the newly redesigned BSD-2000 3D/MR. The benefit of the 3D/MR system is that it allows the oncologist and therapist to accurately visualize tumor and treatment zone temperatures using the MRI.

The new applicator, designed to fit the majority of tesla 1.5 systems, surrounds the patient’s body in the approximate area of the tumor. The patient and applicator are transported inside the MRI. The initial MRI image records the proton resonance frequency image using known baseline temperatures. As the system begins to heat the tumor area, subsequent images are taken. Software calculates the temperature dependent image changes and builds a 3-D temperature map of the tumor and surrounding tissue. Having live temperature data provides the operator easy retargeting, via control software, to ensure the tumor is within the treatment zone and has reached prescribed temperature and coverage. After treatment, applicator can be stored for normal MRI imaging workflow.

RSNA Chicago is approaching fast.  Our booth just shipped out this afternoon. Below are pictures of our booth mock-up we use to help use plan the event.  We are offering a sneak peak of our new BSD-2000 3D/MR Applicator at the show.  Everyone on the team has been working hard all year for this achievement. We will be sharing specifics of the product and our first installation in Germany, later this month.

If you are planning on attending the show, please stop by booth #3257 and be the first to see the new product.  For more details, visit our events page. If you would like to make an appointment with our CEO and our team, please use the form link.

Booth 1

Booth 2

Booth 3

Booth 4

Booth 5

paul robot 4paul robot 2

This year our CTO, Paul Turner, arrived to the American Society for Therapeutic Radiology and Oncology exhibition via a shipping crate.  Our ability to communicate the highly important contribution that Pyrexar hyperthermia systems provide to cancer treatment takes a team.  So how do you bring your entire team to Boston in a fiscally responsible way?  You do it virtually, with a virtual presence robot. Our entire staff at our Salt Lake City headquarters was available to answer attendee questions simply by taking controls remotely of our onsite robot.  "We use this technology in our office everyday" says Mark Falkowski, CEO of Pyrexar, "having control of your virtual presence in the office is different from a Skype meeting, it gives you the autonomy to go just about anywhere".

paul robot 3paul robot 1

Not only was Paul available for meetings and to answer questions, he often posed for photographs during the show.